Search

Your search keyword '"Berlendis, Marialma"' showing total 19 results
Start Over Author "Berlendis, Marialma"
19 results on '"Berlendis, Marialma"'

4. Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features

Author

De Francesco, Maria Antonia, primary, Poiesi, Claudio, additional, Gargiulo, Franco, additional, Bonfanti, Carlo, additional, Pollara, Patrizia, additional, Fiorentini, Simona, additional, Caccuri, Francesca, additional, Carta, Valentina, additional, Mangeri, Lucia, additional, Pellizzeri, Simone, additional, Rizzoni, Damiano, additional, Malerba, Paolo, additional, Salvetti, Massimo, additional, Muiesan, Maria Lorenza, additional, Alberici, Federico, additional, Scolari, Francesco, additional, Pilotto, Andrea, additional, Padovani, Alessandro, additional, Bezzi, Michela, additional, Chiappini, Raffaella, additional, Ricci, Chiara, additional, Castellano, Maurizio, additional, Berlendis, Marialma, additional, Savio, Giulia, additional, Montani, Giovanni, additional, Ronconi, Maurizio, additional, Bove, Sergio, additional, Focà, Emanuele, additional, Tomasoni, Lina, additional, Castelli, Francesco, additional, Rossini, Angelo, additional, Inciardi, Riccardo, additional, Metra, Marco, additional, and Caruso, Arnaldo, additional

Published
2021
Full Text
View/download PDF

6. Bronchiectasis in Italy: data from the national registry IRIDE

Author

Aliberti, Stefano, primary, Sotgiu, Giovanni, additional, Menzella, Francesco, additional, Berlendis, Marialma, additional, Dente, Federico, additional, Ferri, Sebastian, additional, Aiello, Marina, additional, Corsico, Angelo, additional, Conti, Valentina, additional, Battaglia, Salvatore, additional, Comellini, Vittoria, additional, Faverio, Paola, additional, De Juli, Emanuela, additional, Crichton, Megan, additional, Polverino, Eva, additional, Chalmers, James, additional, and Blasi, Francesco, additional

Published
2020
Full Text
View/download PDF

7. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

Author

Toniati, Paola, primary, Piva, Simone, additional, Cattalini, Marco, additional, Garrafa, Emirena, additional, Regola, Francesca, additional, Castelli, Francesco, additional, Franceschini, Franco, additional, Airò, Paolo, additional, Bazzani, Chiara, additional, Beindorf, Eva-Andrea, additional, Berlendis, Marialma, additional, Bezzi, Michela, additional, Bossini, Nicola, additional, Castellano, Maurizio, additional, Cattaneo, Sergio, additional, Cavazzana, Ilaria, additional, Contessi, Giovanni-Battista, additional, Crippa, Massimo, additional, Delbarba, Andrea, additional, De Peri, Elena, additional, Faletti, Angela, additional, Filippini, Matteo, additional, Frassi, Micol, additional, Gaggiotti, Mario, additional, Gorla, Roberto, additional, Lanspa, Michael, additional, Lorenzotti, Silvia, additional, Marino, Rosa, additional, Maroldi, Roberto, additional, Metra, Marco, additional, Matteelli, Alberto, additional, Modina, Denise, additional, Moioli, Giovanni, additional, Montani, Giovanni, additional, Muiesan, Maria-Lorenza, additional, Odolini, Silvia, additional, Peli, Elena, additional, Pesenti, Silvia, additional, Pezzoli, Maria-Chiara, additional, Pirola, Ilenia, additional, Pozzi, Alessandro, additional, Proto, Alessandro, additional, Rasulo, Francesco-Antonio, additional, Renisi, Giulia, additional, Ricci, Chiara, additional, Rizzoni, Damiano, additional, Romanelli, Giuseppe, additional, Rossi, Mara, additional, Salvetti, Massimo, additional, Scolari, Francesco, additional, Signorini, Liana, additional, Taglietti, Marco, additional, Tomasoni, Gabriele, additional, Tomasoni, Lina-Rachele, additional, Turla, Fabio, additional, Valsecchi, Alberto, additional, Zani, Davide, additional, Zuccalà, Francesco, additional, Zunica, Fiammetta, additional, Focà, Emanuele, additional, Andreoli, Laura, additional, and Latronico, Nicola, additional

Published
2020
Full Text
View/download PDF

11. Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE)

Author

Franceschi, Elisa, primary, Aliberti, Stefano, additional, Dente, Federico, additional, Berlendis, Marialma, additional, De Juli, Emanuela, additional, Battaglia, Salvatore, additional, Gramegna, Andrea, additional, Amati, Francesco, additional, Contarini, Martina, additional, Calabrese, Cecilia, additional, Conio, Valentina, additional, Comellini, Vittoria, additional, Crimi, Nunzio, additional, Corsico, Angelo, additional, Faverio, Paola, additional, Ferri, Sebastian, additional, Galeone, Carla, additional, Menzella, Francesco, additional, Nava, Stefano, additional, Paggiaro, Pierluigi, additional, Scichilone, Nicola, additional, Dottorini, Maurizio, additional, Di Matteo, Rosa, additional, Dodaj, Meridiana, additional, Chalmers, James D, additional, Sotgiu, Giovanni, additional, and Blasi, Francesco, additional

Published
2018
Full Text
View/download PDF

12. Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting

Author

Rottoli, Paola, primary, Bargagli, Elena, additional, Bucca, Caterina, additional, Zappa, Maria Cristina, additional, Berlendis, Marialma, additional, Giovanni, Michetti, additional, Caruso, Cristiano, additional, Bartezaghi, Marta, additional, Rigoni, Laura, additional, Canonica, Giorgio Walter, additional, and Macciocchi, Bruno, additional

Published
2017
Full Text
View/download PDF

13. A COPD Case-Finding Program in a Large Cohort of HIV-Infected Persons.

Author

Quiros-Roldan, Eugenia, Pezzoli, Maria Chiara, Berlendis, Marialma, Raffetti, Elena, Ferraresi, Alice, Properzi, Martina, Rodari, Paola, and Castelli, Francesco

Subjects
OBSTRUCTIVE lung disease diagnosis, DIAGNOSTIC errors, HIV-positive persons, MEDICAL equipment, MEDICAL screening, PATIENT compliance, QUESTIONNAIRES, PULMONARY function tests, RESPIRATORY obstructions, SPIROMETRY, HUMAN services programs, PREDICTIVE tests, DATA analysis software, DESCRIPTIVE statistics, CD4 lymphocyte count
Abstract

BACKGROUND: COPD screening guidelines in patients with HIV are lacking, and data about its under-diagnosis are still limited. This study aimed to determinate the feasibility of a case-finding program and the prevalence of COPD under-diagnosis in a large cohort of HIV-infected subjects. METHODS: All out-patients attending their routine visit for HIV monitoring at Spedali Civili General Hospital in Brescia, Italy, from February 2015 to January 2016, were enrolled. The case-finding program was structured in three steps: questionnaire administration, pre-bronchodilator spirometry testing measured with a portable spirometer, and post-bronchodilator diagnostic spirometry during a pulmonology appointment. RESULTS: A total of 1,463 subjects were included; the average age was 46.2 ± 10.3 y. Two hundred eighty-two subjects had a positive questionnaire; 190 completed portable spirometry, and approximately 34% (65 of 190 subjects) reported respiratory impairment; of these 65 subjects, 33 completed diagnostic spirometry, and 66.7% (22 of 33) showed evidence of COPD, including 2 subjects with severe airway obstruction (GOLD stage 3, according to the Global Initiative for Chronic Obstructive Lung Disease). High dropout rates were observed in our program. Individuals with COPD exacerbations showed lower CD4+ cell counts at screening compared to those without acute worsening of symptoms (534 cells/mm³ for subjects with GOLD 1 exacerbations and 495 cells/mm³ for subjects with GOLD 2 exacerbations vs 781 cells/mm³ for those without acute worsening of symptoms). The positive predictive value of the COPD screening questionnaire and portable spirometry was 33.8%. CONCLUSIONS: COPD may be underdiagnosed in HIV-infected people, and case-finding programs are an urgent issue to address as part of routine practice in these individuals. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

17. Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) study.

Author

Colombo, Delia, Zagni, Emanuela, Ferri, Fabio, Canonica, Giorgio Walter, the PROXIMA study centers, Astarita, Corrado, Balbo, Piero, Berlendis, Marialma, Bruni, Giacomo, Bucca, Caterina, Corsico, Angelo Guido, Foresi, Antonio, Macciocchi, Bruno, Michetti, Giovanni, Montera, Mariacarmela, Palange, Paolo, Pareo, Carlo, Polla, Biagio, Polosa, Riccardo, and Puddu, Enrico

Subjects
QUALITY of life, ASTHMA, SENSORY perception, GENDER differences (Psychology), ATTITUDES toward illness
Abstract

Background: Gender differences in asthma perception and control have been reported. The PROXIMA observational study assessed these outcomes in a cohort of Italian severe allergic asthma (SAA) patients. This post hoc analysis of the PROXIMA results was aimed at assessing gender differences in SAA in a real-world setting, focusing on disease perception and impact on quality of life (QoL). Methods: The PROXIMA study was an observational, multicenter study, consisting of a cross-sectional and a prospective longitudinal phase, including adult outpatients diagnosed with SAA at step 4 requiring a therapeutic step-up. Patients on omalizumab treatment at baseline were included in the 12-month longitudinal phase. Disease control was assessed by the Asthma Control Questionnaire (ACQ) score, patients' disease perception by the Brief Illness Perception Questionnaire (BIPQ), and QoL by the EuroQoL five-dimensional three-level questionnaire (EQ-5D-3 L) at baseline and after 6 and 12 months. Two regression models were used to evaluate the association between gender and BIPQ total score and EQ-5D-3L score, respectively. Results: 357 patients (65% females) were analyzed for the cross-sectional phase and 99 (62.6% females) for the longitudinal phase. The prevalence of perennial and seasonal aeroallergens was similar between genders. ACQ score decreased similarly during omalizumab treatment at 6 and 12 months in both genders; no gender differences were observed in control rates. Asthma perception was worse among females at all study visits reaching statistical significance at 12 months (mean (SD) B-IPQ total score 41.8 (9.4) vs 35.6 (12.0); T test p-value (males vs females) < 0.05). Statistically significant gender differences were observed for some specific items, with males reporting less symptom experience, concern about the disease, and emotional impact at 12-months. The results of the multivariate regression model for repeated measures showed that overall treatment with omalizumab improved disease perception overtime regardless from gender. Males reported a significantly better QoL compared to females at both 6 and 12 months. Conclusions: In this real-world setting, females confirmed to have a worse perception of asthma, feel it as more symptomatic and suffer a greater impact on their QoL, even though having similar baseline severity and obtaining similar level of control. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

18. Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE)

Author

Nunzio Crimi, Carla Galeone, Stefano Aliberti, Angelo Corsico, Martina Contarini, Meridiana Dodaj, Valentina Conio, Nicola Scichilone, Vittoria Comellini, Andrea Gramegna, Emanuela De Juli, Giovanni Sotgiu, Francesco Blasi, Paola Faverio, Francesco Menzella, Francesco Amati, Salvatore Battaglia, Elisa Franceschi, Marialma Berlendis, Pierluigi Paggiaro, Cecilia Calabrese, Sebastian Ferri, Federico L. Dente, Stefano Nava, Rosa Di Matteo, Maurizio Dottorini, James D. Chalmers, Franceschi, Elisa, Aliberti, Stefano, Dente, Federico, Berlendis, Marialma, De Juli, Emanuela, Battaglia, Salvatore, Gramegna, Andrea, Amati, Francesco, Contarini, Martina, Calabrese, Cecilia, Conio, Valentina, Comellini, Vittoria, Crimi, Nunzio, Corsico, Angelo, Faverio, Paola, Ferri, Sebastian, Galeone, Carla, Menzella, Francesco, Nava, Stefano, Paggiaro, Pierluigi, Scichilone, Nicola, Dottorini, Maurizio, Di Matteo, Rosa, Dodaj, Meridiana, D Chalmers, Jame, Sotgiu, Giovanni, and Blasi, Francesco

Subjects
medicine.medical_specialty, Bronchiectasis, Sputum colour, Copd patients, business.industry, Sputum Production, medicine.disease, Disease severity, Internal medicine, Secondary analysis, Cohort, medicine, Sputum, medicine.symptom, business
Abstract

Introduction: Murray sputum colour chart stratifies patients according to the presence of mucous (M), muco-purulent (MP) or purulent (P) sputum, and has not been validated in Bx yet. We aimed to validate this scale across a large Italian cohort of Bx patients. Methods: A secondary analysis of the IRIDE database was conducted including adults with Bx and daily sputum production enrolled across 13 Italian centres between 2014 and 2017. M vs. MP vs. P sputum producers were identified and clinical, functional and microbiological data were collected. Clinical outcomes during a two-year follow up period were evaluated in the Monza and Milan cohorts. A sensitivity analysis excluding COPD patients was conducted. Results: 448 patients were enrolled (65% female, median age 68 years): 45% belonged to Group M, 40% to Group MP and 15% to Group P. Significant differences (M vs. MP vs. P) were detected in terms of rate of chronic infection due to any bacteria (30% vs. 47% vs. 71%, p

Published
2018

19. Quality standards for the management of bronchiectasis in Italy: A national audit

Author

Maria Pia Foschino Barbaro, Stefano Aliberti, Valentina Conti, Francesco De Blasio, Mauro Carone, Antonio Foresi, Marina Saetta, Marialma Berlendis, Giuseppe Girbino, Pierachille Santus, Michele Vitacca, Salvatore Lo Cicero, Donato Lacedonia, Stefano Centanni, Nicola Ciancio, Vittoria Comellini, Daniela Bonardi, Fulvio Braido, G. F. Schiraldi, Francesca Becciu, Angelo Corsico, Nunzio Crimi, Giuseppe Francesco Sferrazza Papa, Adam T. Hill, Pietro Schino, Piero Ceriana, Alessandro Vatrella, Francesco Menzella, Alessandro Sanduzzi, Carmela Morrone, Pierfranco Usai, Mario Malerba, Caterina Conti, Marco Basile, Sergio Celestino Conte, Marco Mantero, Salvatore Battaglia, Francesco Blasi, Kim Lokar-Oliani, James D. Chalmers, Vincenzo Mastrosimone, Claudia Stochino, Aliberti, S., Hill, A., Mantero, M., Battaglia, S., Centanni, S., Cicero, S., Lacedonia, D., Saetta, M., Chalmers, J., Blasi, F., Morrone, C., Basile, M., Papa, G., Conti, C., Barbaro, M., Lokar-Oliani, K., Schino, P., Vitacca, M., Menzella, F., Sanduzzi, A., Usai, P., Carone, M., Bonardi, D., Crimi, N., Schiraldi, G., Corsico, A., Malerba, M., Becciu, F., Santus, P., Girbino, G., Foresi, A., Comellini, V., Stochino, C., Ceriana, P., Conti, V., Braido, F., Mastrosimone, V., Ciancio, N., Berlendis, M., De Blasio, F., Conte, S., Vatrella, A., Aliberti, Stefano, Hill, Adam T., Mantero, Marco, Battaglia, Salvatore, Centanni, Stefano, Cicero, Salvatore Lo, Lacedonia, Donato, Saetta, Marina, Chalmers, James D., Blasi, Francesco, Morrone, Carmela, Basile, Marco, Papa, Giuseppe Francesco Sferrazza, Conti, Caterina, Barbaro, Maria Pia Foschino, Lokar Oliani, Kim, Schino, Pietro, Vitacca, Michele, Menzella, Francesco, SANDUZZI ZAMPARELLI, Alessandro, Usai, Pierfranco, Carone, Mauro, Bonardi, Daniela Rita, Crimi, Nunzio, Schiraldi, Gianfranco, Corsico, Angelo, Malerba, Mario, Becciu, Francesca, Santus, Pierachille, Girbino, Giuseppe, Foresi, Antonio, Comellini, Vittoria, Stochino, Claudia, Ceriana, Piero, Conti, Valentina, Braido, Fulvio, Mastrosimone, Vincenzo, Ciancio, Nicola, Berlendis, Marialma, De Blasio, Francesco, Conte, Sergio Celestino, and Vatrella, Alessandro

Subjects
Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, bronchiectasis, media_common.quotation_subject, Symptom Flare Up, Medical audit, Settore MED/10 - Malattie Dell'Apparato Respiratorio, 03 medical and health sciences, 0302 clinical medicine, medicine, Prevalence, Humans, Quality (business), Pseudomonas Infections, 030212 general & internal medicine, Intensive care medicine, National audit, media_common, Aged, Medical Audit, Bronchiectasis, business.industry, Medicine (all), Middle Aged, medicine.disease, Anti-Bacterial Agents, Patient Care Management, 030228 respiratory system, Italy, Needs assessment, Pseudomonas aeruginosa, Female, business, Needs Assessment
Abstract

Although historically considered a neglected disease, bronchiectasis has become a disease of renewed interest over recent decades in light of an increase in prevalence and a substantial burden on healthcare systems. In 2010, the British Thoracic Society (BTS) published guidelines on the management of bronchiectasis in adults, along with specific quality standards. To date, these represent the only quality standards available in Europe. These have been tested over a number of years in the UK with progressive improvements in the standard of care. No national guidelines are available in Italy and no indications on which guideline should be followed have been given by the Italian Society of Respiratory Medicine (SIP). There are limited published data on the quality of bronchiectasis care in Europe outside of the UK. The BTS standards have not been tested in continental Europe or in Italy, where information on characteristics and management of bronchiectasis patients are lacking.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results